Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Endologix

Biotech & Life Sciences · Santa Rosa, United States · Founded 1992 · IPO 1996 Thoroughbred

Developer and manufacturer of minimally invasive treatments for aortic disorders

Revenue
$95M
Latest reported FY

Global footprint

Where Endologix has talent and traffic

Workforce by country
🇺🇸 United States · Santa Rosa HQ
Book a demo for the full country breakdown
Web traffic by country
5.4K monthly visits
across markets
🇺🇸 United States63%
🇮🇳 India9.3%
Top 2 markets shown

Capital deployed

Endologix's 3 investments and acquisitions.

Every disclosed deal where Endologix appeared as a backer or acquirer, 2010–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Endologix's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Endologix's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Endologix

        An AI-synthesized read of the highest-engagement posts about Endologix on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Endologix on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.